Circulating FGF21 levels are progressively increased from the early to end stages of chronic kidney diseases and are associated with renal function in Chinese.
BACKGROUND: Fibroblast growth factor 21 (FGF21) is a hepatic hormone involved in the regulation of lipid and carbohydrate metabolism. This study aims to test the hypothesis that elevated FGF21 concentrations are associated with the change of renal function and the presence of left ventricular hypert...
Main Authors: | Zhuofeng Lin, Zhihong Zhou, Yanlong Liu, Qi Gong, Xinxin Yan, Jian Xiao, Xiaojie Wang, Shaoqiang Lin, Wenke Feng, Xiaokun Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2011-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3078122?pdf=render |
Similar Items
-
Serum levels of FGF-21 are increased in coronary heart disease patients and are independently associated with adverse lipid profile.
by: Zhuofeng Lin, et al.
Published: (2010-01-01) -
SIRT1 Mediates Effects of FGF21 to Ameliorate Cisplatin-Induced Acute Kidney Injury
by: Qiongzhen Chen, et al.
Published: (2020-03-01) -
FGF21 mediates alcohol-induced adipose tissue lipolysis by activation of systemic release of catecholamine in mice[S]
by: Cuiqing Zhao, et al.
Published: (2015-08-01) -
Association between FGF19, FGF21 and lipocalin-2, and diabetes progression in PCOS
by: Feifei Cheng, et al.
Published: (2021-10-01) -
Physiological and Pharmacological Roles of FGF21 in Cardiovascular Diseases
by: Peng Cheng, et al.
Published: (2016-01-01)